C12N 2710/24222
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2710/24222 (New viral proteins or individual genes, new structural or functional aspects of) appears on 12 US grants and 17 published applications in this corpus.
Search patents in C12N- Granted patents
- 12
- Published applications
- 17
- Assignees
- 12
- Inventors
- 27
- Latest grant
- 29 Mar 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 1 | 4 |
| 2004 | 3 | 3 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 2 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Recombinant Orf virus vector29 Mar 2022US 11,286,500 B2Eberhard Karls Universität Tübingen Medizinische Fakultät
- Method of treatment using oncolytic viruses6 Apr 2021US 10,967,015 B2New York University
- Recombinant proteins of parapdxvirus ovis and pharmaceutical compositions therefrom25 Jul 2017US 9,714,272 B2AiCuris GmbH & Co. KG
- Recombinant proteins of Parapoxvirus ovis and pharmaceutical compositions therefrom7 Oct 2014US 8,852,577 B2AiCuris GmbH & Co. KG
- Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom22 Jan 2013US 8,357,363 B2AiCuris GmbH & Co. KG
- Mutant orf viruses and uses thereof19 Jun 2025US 2025/0197815 A9Suzhou Prajna Biotech Co., Ltd.
- Modified parapoxvirus having increased immunogenicity8 Feb 2024US 2024/0043870 A1Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet
- Mutant orf viruses and uses thereof26 Oct 2023US 2023/0340424 A1Suzhou Prajna Biotech Co., Ltd.
- Recombinant orf virus vector30 Jun 2022US 2022/0204992 A1Eberhard Karls Universität Tübingen Medizinische Fakultät
- Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom26 Sep 2019US 2019/0292231 A1AiCuris GmbH & Co. KG
Most cited
By later US patents
- Nucleic acid and polypeptide sequences useful as adjuvants24US 6,752,995 B2Board of Regents, The University of Texas System · 2004
- Vascular endothelial growth factor-like protein from orf viruses binds and activates mammalian VEGF receptor-2, and uses thereof8US 6,541,008 B1Ludwig Institute for Cancer Research · 2003
- Parapoxviruses containing foreign DNA, their production and their use in vaccines6US 6,365,393 B1Bayer Aktiengesellschaft · 2002
- Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom3US 8,357,363 B2AiCuris GmbH & Co. KG · 2013